
Kymera Therapeutics, Inc.
USD73.21
+1.92 (+2.69%)
CEO
Nello Mainolfi
IPO Date
2020-08-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$70.99
Prev. Close
$71.29
Day Low
$69.48
Day High
$73.94
52W Low
$36.65
52W High
$103.00
Market Cap
$6.02B
Volume
0.85M
| 26 Feb 2026 |
| Piper Sandler |
| Overweight |
| Overweight |
| maintain |
| 26 Feb 2026 | BTIG | Buy | Buy | maintain |
| 3 Feb 2026 | BTIG | Buy | Buy | maintain |
| 28 Jan 2026 | Barclays | Overweight | Overweight | maintain |
| 15 Jan 2026 | BTIG | Buy | Buy | maintain |
| 6 Jan 2026 | Wolfe Research | Outperform | Peer Perform | downgrade |
| 22 Dec 2025 | B. Riley Securities | Buy | Buy | maintain |